GLOBAL LIQUIDITY DESK | LONDON FIX: 16:00 GMT | NEW YORK CASH: ACTIVE | RAW ECN SPREAD: 0.0 PIPS | LATENCY: 4.2ms DIRECT
TLS 1.3 256-BIT ENCRYPTED | 24/7 VIP CONCIERGE
Back to Live Wire • Stocks • ‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
Live Signals Terminal
Stocks 📡 Source: MarketWatch
📅 Oct 13, 2026 · 18:39 • 👁️ 2,403 views

‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks

‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
The Federal Trade Commission and seven states say Shkreli should be held in contempt
\n